Literature DB >> 24920773

Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility.

Noriyuki Nagano1, Yukiko Nagano2, Masami Toyama1, Kouji Kimura3, Keigo Shibayama2, Yoshichika Arakawa4.   

Abstract

We characterized penicillin-susceptible group B streptococcal (PSGBS) clinical isolates exhibiting no growth inhibition zone around a ceftibuten disk (CTB(r) PSGBS). The CTB(r) PSGBS isolates, for which augmented MICs of cefaclor and ceftizoxime were found, shared a T394A substitution in penicillin-binding protein 2X (PBP 2X) and a T567I substitution in PBP 2B, together with an additional G429S substitution in PBP 2X or a T145A substitution in PBP 1A, although the T145A substitution in the transglycosidase domain of PBP 1A would have no effect on the level of resistance to ceftibuten.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24920773      PMCID： PMC4313170          DOI： 10.1128/JCM.01291-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Molecular characterization of group B streptococci with reduced penicillin susceptibility recurrently isolated from a sacral decubitus ulcer.

Authors:  Noriyuki Nagano; Kouji Kimura; Yukiko Nagano; Hiroaki Yakumaru; Yoshichika Arakawa
Journal:  J Antimicrob Chemother       Date:  2009-10-16       Impact factor: 5.790

2.  Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.

Authors:  Noriyuki Nagano; Yukiko Nagano; Kouji Kimura; Kiyoko Tamai; Hideji Yanagisawa; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

3.  Ability of the VITEK(R) 2 system to detect group B streptococci with reduced penicillin susceptibility (PRGBS).

Authors:  Kouji Kimura; Noriyuki Nagano; Yukiko Nagano; Jun-ichi Wachino; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Antimicrob Chemother       Date:  2013-02-01       Impact factor: 5.790

4.  First molecular characterization of group B streptococci with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Satowa Suzuki; Jun-ichi Wachino; Hiroshi Kurokawa; Kunikazu Yamane; Naohiro Shibata; Noriyuki Nagano; Haru Kato; Keigo Shibayama; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2008-05-19       Impact factor: 5.191

5.  Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics.

Authors:  Samira Dahesh; Mary E Hensler; Nina M Van Sorge; Robert E Gertz; Stephanie Schrag; Victor Nizet; Bernard W Beall
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

6.  Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility.

Authors:  Kouji Kimura; Jun-Ichi Wachino; Hiroshi Kurokawa; Satowa Suzuki; Kunikazu Yamane; Naohiro Shibata; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2009-10-07       Impact factor: 5.948

7.  Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

Authors:  Christina R Phares; Ruth Lynfield; Monica M Farley; Janet Mohle-Boetani; Lee H Harrison; Susan Petit; Allen S Craig; William Schaffner; Shelley M Zansky; Ken Gershman; Karen R Stefonek; Bernadette A Albanese; Elizabeth R Zell; Anne Schuchat; Stephanie J Schrag
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

8.  Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections.

Authors:  Somay Yamagata Murayama; Chizuko Seki; Hiroshi Sakata; Katsuhiko Sunaoshi; Eiichi Nakayama; Satoshi Iwata; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2009-03-30       Impact factor: 5.191

9.  Multilocus sequence typing system for group B streptococcus.

Authors:  Nicola Jones; John F Bohnsack; Shinji Takahashi; Karen A Oliver; Man-Suen Chan; Frank Kunst; Philippe Glaser; Christophe Rusniok; Derrick W M Crook; Rosalind M Harding; Naiel Bisharat; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Invasive group B streptococcal infections in infants, France.

Authors:  Claire Poyart; Hélène Réglier-Poupet; Asmaa Tazi; Annick Billoët; Nicolas Dmytruk; Philippe Bidet; Edouard Bingen; Josette Raymond; Patrick Trieu-Cuot
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883
View more
  9 in total

1.  A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing Myositis.

Authors:  Randall J Olsen; Luchang Zhu; James M Musser
Journal:  Am J Pathol       Date:  2020-05-11       Impact factor: 4.307

2.  Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread.

Authors:  James M Musser; Stephen B Beres; Luchang Zhu; Randall J Olsen; Jaana Vuopio; Hanne-Leena Hyyryläinen; Kirsi Gröndahl-Yli-Hannuksela; Karl G Kristinsson; Jessica Darenberg; Birgitta Henriques-Normark; Steen Hoffmann; Dominque A Caugant; Andrew J Smith; Diane S J Lindsay; David M Boragine; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

3.  Invasive Group A Streptococcal Penicillin Binding Protein 2× Variants Associated with Reduced Susceptibility to β-Lactam Antibiotics in the United States, 2015-2021.

Authors:  Sopio Chochua; Benjamin Metcalf; Zhongya Li; Saundra Mathis; Theresa Tran; Joy Rivers; Katherine E Fleming-Dutra; Yuan Li; Lesley McGee; Bernard Beall
Journal:  Antimicrob Agents Chemother       Date:  2022-08-15       Impact factor: 5.938

4.  Genomic Traits Associated with Virulence and Antimicrobial Resistance of Invasive Group B Streptococcus Isolates with Reduced Penicillin Susceptibility from Elderly Adults.

Authors:  Shota Koide; Yukiko Nagano; Shino Takizawa; Kanae Sakaguchi; Eiji Soga; Wataru Hayashi; Mizuki Tanabe; Tomohiro Denda; Kouji Kimura; Yoshichika Arakawa; Noriyuki Nagano
Journal:  Microbiol Spectr       Date:  2022-05-31

5.  Streptococcus agalactiae infection in cancer patients: a five-year study.

Authors:  B A S Pimentel; C A S Martins; J C Mendonça; P S D Miranda; G F Sanches; A L Mattos-Guaraldi; P E Nagao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

6.  High isolation rate and multidrug resistance tendency of penicillin-susceptible group B Streptococcus with reduced ceftibuten susceptibility in Japan.

Authors:  Hirotsugu Banno; Kouji Kimura; Tomomi Seki; Wanchun Jin; Jun-Ichi Wachino; Keiko Yamada; Noriyuki Nagano; Yoshichika Arakawa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-17       Impact factor: 3.267

7.  Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998-2018.

Authors:  Miwako Kobayashi; Lesley McGee; Sopio Chochua; Mirasol Apostol; Nisha B Alden; Monica M Farley; Lee H Harrison; Ruth Lynfield; Paula Snippes Vagnone; Chad Smelser; Alison Muse; Ann R Thomas; Li Deng; Benjamin J Metcalf; Bernard W Beall; Stephanie J Schrag
Journal:  Open Forum Infect Dis       Date:  2020-12-21       Impact factor: 3.835

8.  Isolation of Group A Streptococci with Reduced In Vitro β-Lactam Susceptibility Harboring Amino Acid Substitutions in Penicillin-Binding Proteins in Japan.

Authors:  Tsubasa Ikeda; Rihito Suzuki; Wanchun Jin; Jun-Ichi Wachino; Yoshichika Arakawa; Kouji Kimura
Journal:  Antimicrob Agents Chemother       Date:  2021-10-04       Impact factor: 5.191

9.  Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.

Authors:  Mark van der Linden; Rafael Mamede; Natascha Levina; Peter Helwig; Pedro Vila-Cerqueira; João André Carriço; José Melo-Cristino; Mário Ramirez; Elisabete R Martins
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.